Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers

被引：0
|
作者：
Xue Chen
Feng Yang
Jiao Zhao
Qi Tang
Jianfu Heng
Jun Deng
Jin Zhang
Yong Chen
Kunyan Li
Jing Wang
机构：
[1] Central South University,Early Clinical Trial Center, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine
[2] Central South University,Office of National Drug Clinical Trial Institution, Hunan Cancer Hospital and The Affiliated Cancer Hospital of Xiangya School of Medicine
来源：
Cancer Chemotherapy and Pharmacology | 2022年 / 89卷
关键词：
Fuzuloparib; Fluconazole; CYP3A4; Drug–drug interaction (DDI); PARP inhibitor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：141 / 148
页数：7
相关论文
共 50 条
  • [1] Effect of fluconazole on the pharmacokinetics of fuzuloparib: an open-label, crossover study in Chinese healthy male volunteers
    Chen, Xue
    Yang, Feng
    Zhao, Jiao
    Tang, Qi
    Heng, Jianfu
    Deng, Jun
    Zhang, Jin
    Chen, Yong
    Li, Kunyan
    Wang, Jing
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2022, 89 (01) : 141 - 148
  • [2] A randomized, open-label, two-period crossover bridging study on fuzuloparib capsules of different specifications in healthy Chinese volunteers
    Jiang, Xin
    Tao, Ye
    Liu, Yanping
    Shi, Ping
    Li, Ting
    Sun, Feifei
    Cao, Yu
    Wang, Chenjing
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (03) : 1087 - 1093
  • [3] Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects
    Linlin Hu
    Ting Dou
    Qiuyue Sun
    Lu Tang
    Mingmin Cai
    Wei Qian
    Huiping Wang
    [J]. Investigational New Drugs, 2023, 41 : 276 - 283
  • [4] The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers
    Zhang, Qiao
    Kai, Jiejing
    Zhai, You
    Xu, Nana
    Shentu, Jianzhong
    Zhang, Yanyan
    Liang, Yanjuan
    Wang, Yuya
    Wu, Lihua
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (01) : 84 - 90
  • [5] Effect of a moderate CYP3A inducer efavirenz on the pharmacokinetics of fuzuloparib: An open-label, fixed sequence study in Chinese healthy male subjects
    Hu, Linlin
    Dou, Ting
    Sun, Qiuyue
    Tang, Lu
    Cai, Mingmin
    Qian, Wei
    Wang, Huiping
    [J]. INVESTIGATIONAL NEW DRUGS, 2023, 41 (02) : 276 - 283
  • [6] A Randomized, Open-Label, Crossover Study to Evaluate the Pharmacokinetics of Empagliflozin and Linagliptin After Coadministration in Healthy Male Volunteers
    Friedrich, Christian
    Metzmann, Katrin
    Rose, Peter
    Mattheus, Michaela
    Pinnetti, Sabine
    Woerle, Hans J.
    [J]. CLINICAL THERAPEUTICS, 2013, 35 (01) : A33 - A42
  • [7] Open-label, nonrandomized study of the effects of gatifloxacin on the pharmacokinetics of midazolam in healthy male volunteers
    Grasela, DM
    LaCreta, FP
    Kollia, GD
    Randall, DM
    Uderman, HD
    [J]. PHARMACOTHERAPY, 2000, 20 (03): : 330 - 335
  • [8] Pharmacokinetics and Bioequivalence of Misoprostol Tablets: An Open-Label, Randomized, Single-dose, Crossover Study With Healthy Chinese Volunteers
    Wang, Shumin
    Wu, Feng
    Han, Ying
    Ni, Siyang
    Guo, Shaojie
    Dai, Yuyang
    Xia, Qiang
    Chang, Di
    Zhang, Ju
    Wei, Huiwen
    Zhao, Xiuli
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2022, 11 (08): : 949 - 956
  • [9] Pharmacokinetics and bioequivalence of sunitinib and Sutent® in Chinese healthy subjects: an open-label, randomized, crossover study
    Wang, Yanli
    Deng, Qiaohuan
    Gao, Zhenyue
    Liu, Guangwen
    Su, Zhengjie
    Zhao, Yicheng
    Zhang, Lixiu
    Yang, Haimiao
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [10] Effect of itraconazole and fluconazole on the pharmacokinetics of valemetostat: An open-label, phase I study in healthy subjects
    Tachibana, Masaya
    Matsuki, Shunji
    Maekawa, Yutaro
    Kuroda, Kana
    Shimizu, Takako
    Tsutsumi, Junko
    Ishizuka, Hitoshi
    [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2023, 16 (11): : 2153 - 2162
12345